← Back to all events
MINTSTAT News (medicine)Jul 10, 2026

Roche ends Huntington’s gene-silencing programs

View original article →
Final score
-3.14
Confidence
8/10
Amount
250K CBWD

AI justification

[Auto-resolved by learned corrector: learned-map — A=MINT/B=MINT -> MINT (human chose this in 87% of 272 past reviews)] Withdrawal of targeted therapy for incurable disease without guaranteed alternatives. | Roche's withdrawal of Huntington's gene-silencing programs halts a promising therapeutic avenue for a severe, incurable disease, prioritizing risk management over patient needs. While it may redirect resources toward other innovations, the immediate loss of a targeted approach for patients o